Sanquin
Deals on record
1
Common Fundraising Type
Seed
Alveron Pharma
Pharmaceuticals • Intracranial Hemorrhage
Alveron Pharma develops a drug, OKL-1111, to treat intracranial haemorrhage by reversing the effects of anticoagulants and platelet inhibitors.